Position in EPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$276,930
-$4,307 QoQ
Shares Held
38,250
+2.7% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 54 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. EPRX ranks #55 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in EPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $276,930 | 38,250 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $281,237 | 37,250 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $219,775 | 37,250 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $214,560 | 37,250 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $171,380 | 52,250 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $179,897 | 56,750 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $129,527 | 49,250 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $127,065 | 49,250 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||